Case Study of the Standardized Nutrition Care Process in a Patient with Diabetes Mellitus

Authors

  • Andi Rizki Julianti Department Nutrition Health Polytechnic of Makassar
  • Sukmawati Sukmawati Department of Nutrition, Poltekkes Kemenkes, Makassar, Indonesia
  • Hendrayati Hendrayati Department of Nutrition, Poltekkes Kemenkes, Makassar, Indonesia

Keywords:

Diabetes Mellitus, , Standardized Nutrition Care Process, Medical Nutrition Therapy

Abstract

In Indonesia, the number of people living with DM reached 19.5 million in 2021, making it the country with the fifth highest prevalence worldwide. This study aimed to assess the standardized nutritional care provided to a DM patient at RSAU Dr. Dody Sardjoto through an observational case study involving a single subject. Nutritional assessment indicated the patient was overweight and exhibited elevated blood pressure. Over a three-day monitoring period, nutrient intake exceeded daily requirements: energy intake ranged from 110–120%, protein 96–103%, fat 138–153%, and carbohydrates 106–128%. In conclusion, the patient was prescribed a 1500 kcal diabetic diet (DM RG). A gradual reduction in random blood glucose levels was observed, from 281 mg/dL on day one to 232 mg/dL on day three, although levels remained above the normal range

Downloads

Download data is not yet available.

References

Sutandyo N, Firna E, Agustina J, Prayogo N, Widjaja L. Clinicopathology Profile and Bone Involvement of Multiple Myeloma Patients in Dharmais National Cancer Hospital, Indonesia. Asian Pacific Journal of Cancer Prevention. 2015 Oct 6;16(15):6261–5.

An ZY, Fu H, He Y, Zhu X, Huang QS, Wu J, et al. Projected Global Trends in Hematological Malignancies: Incidence, Mortality, and Disability-Adjusted Life Years from 2020 to 2030. Blood. 2023 Nov 2;142(Supplement 1):3810–3810. Cowan AJ, Allen C, Barac A, Basaleem H, Bensenor I, Curado MP, et al. Global Burden of Multiple Myeloma. JAMA Oncol. 2018 Sep 1;4(9):1221.

Fazio M, Del Fabro V, Parrinello NL, Allegra A, Markovic U, Botta C, et al. Multiple Myeloma in 2023 Ways: From Trials to Real Life. Current Oncology. 2023 Nov 3;30(11):9710–33.

Cowan AJ, Allen C, Barac A, Basaleem H, Bensenor I, Curado MP, et al. Global Burden of Multiple Myeloma. JAMA Oncol. 2018 Sep 1;4(9):1221.

Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, et al. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. Journal of Clinical Oncology. 2015 Sep 10;33(26):2863–9.

Palumbo A, Anderson K, Battista SG. Medical Progress Multiple Myeloma.

Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022 Aug 23;97(8):1086–107.

Kumar SK, Rajkumar V, Kyle RA, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046. DOI: 10.1038/nrdp.2017.46

Gau YC, Yeh TJ, Hsu CM, Hsiao SY, Hsiao HH. Pathogenesis and Treatment of Myeloma-Related Bone Disease. Int J Mol Sci. 2022;23(6):3112. Published 2022 Mar 14. doi:10.3390/ijms23063112

Teramachi J, Miki H, Nakamura S, Hiasa M, Harada T, Abe M. Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents. J Bone Miner Metab. 2023;41(3):388-

doi:10.1007/s00774-023-01403-4

Facon T, Kumar S, Plesner T, et al. Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma. N Engl J Med. 2019;380(22):2104-2115. DOI: 10.1056/NEJMoa1817249

Annadatha A, Acharya S, Shukla S, Bhawane A, Varma A, Andhale A. Multiple Myeloma presenting as Hypercalcemic Crisis: A case report. Medical Science. 2020;24(105),3148-3152

Costa LJ, Chhabra S, Godby KN, et al. Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd) Induction, Autologous Transplantation and Post-Transplant, Response-Adapted, Measurable Residual Disease (MRD)-Based Dara-Krd Consolidation in Patients with Newly Diagnosed Multiple Myeloma (NDMM). Blood. 2019;134(Supplement_1):860. DOI: 10.1182/blood-2019-123170

Raje N, Berdeja J, Lin Y, et al. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma. N Engl J Med. 2019;380(18):1726-1737. DOI: 10.1056/NEJMoa1817226

Perez JM, Graham RJ, Mehta NM, Martinez EE. Nutrition support in children with medical complexity and chronic critical illness: A narrative review. Nutrition in Clinical Practice. 2025 Feb;40(1):54-63.

Raiten DJ, Steiber AL, Bremer AA. The Value of Integrating the Nutritional Ecology into the Nutrition Care Continuum—A Conceptual and Systems Approach. Advances in Nutrition. 2025 Mar 1;16(3):100385.

LaBonte LR, Papoutsakis C, Lewis S, Colin C. Development and validation of the Nutrition Care Process Assessment of Brief Level of Expertise screening tool. Frontiers in Nutrition. 2025 May 2;12:1572181.

Sohret EN, Tekerek NU, Koker A, Dursun O. Evaluation of parenteral nutrition practices in pediatric intensive care units. Nutrition Clinique et Métabolisme. 2025 Mar 1;39(1):37-43.

Mansour M, Knebusch N, Ontaneda A, Vazquez S, Daughtry J, Typpo K, Coss-Bu JA. Nutrition Provision in Pediatric Extracorporeal Membrane Oxygenation: Evidence, Challenges, and Clinical Considerations. Nutrients. 2025 Apr 30;17(9):1553.

Ge G, Zelig R, Brown T, Radler DR. A review of the effect of the ketogenic diet on glycemic control in adults with type 2 diabetes. Precision Nutrition. 2025 Mar 1;4(1):e00100.

Zooravar D, Soltani P, Khezri S. Mediterranean diet and diabetic microvascular complications: a systematic review and meta-analysis. BMC nutrition. 2025 Apr 2;11(1):66.

Published

2025-05-30

How to Cite

1.
Julianti AR, Sukmawati S, Hendrayati H. Case Study of the Standardized Nutrition Care Process in a Patient with Diabetes Mellitus. JHCD [Internet]. 2025 May 30 [cited 2025 Oct. 13];1(1):29-32. Available from: https://www.journalmpci.com/index.php/jhcd/article/view/598

Issue

Section

Articles